Fingerprint
Dive into the research topics of 'A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
Christos Fountzilas, Ravi Chhatrala, Nikhil Khushalani, Wei Tan, Charles LeVea, Alan Hutson, Chris Tucker, Wen Wee Ma, Graham Warren, Patrick Boland, Renuka Iyer
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations